1Sarosi GA. Fungal infections and their treatment in the intensive care unit[J]. Curr Opin Crit Care. 2006, 12(5):464-469.
2Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts:implications for diagnosis and management[J]. Clin Infect Dis. 2002, 35(8) : 909-920.
3Arikan S, Lozano-Chiu M, Paetznick V, et al. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Agents Chemother, 2002, 46(1):245-247.
4Linares Mj, Charriel G. Solis F, et al. Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods[J].J Clin Microbiol, 2005, 43(1):250-253.
5Gonzalez GM, Folhergill AW, Sullon DA, et al. In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi[J]. Med Mycol, 2005, 43 (3):281-284.
6Lozano-Chiu M, Arikan S, Paetznick VL. et al. Treatment of routine fusariosis with SCH 56592[J]. Antimicrob Agents Chemother, 1999, 43(3):589-591.
7Perfect JR, Marr KA,Walsh TJ, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections[J]. Clin Infect Dis, 2003, 36(9):1122-1131.
8Raad I, Hachem R, Herbrecht R, et al. Posaconazole for fusarium infections:results of two clinical studies[J]. Clin Microbiol Infect, 2004, 10(Suppl 3):42.
9Segal BH, Barnhart I.A, Anderson VL, et al. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection[J]. Clin Infect Dis, 2005, 4t)(11):1684-1688.
10Mellinghoff LIK, Winston Dj, Mukwaya G, et al. Treatment of scedosporium apiospermum brain abscesses with posaconazole[J]. Clin Infect Dis, 2002, 34(12):1648-1650.
8Togashi RH, Aguiar FM, Ferreira DB, et al. Pulmonary and extrapulmonary coccidioidomycosis : three cases in an endemic area in the state of Ceara, Brazil. J Bras Pneumol, 2009, 35:275- 279.
9Al-Daraji WI, Al-Mahmoud RM, Ali MA. Disseminated coccidioidomycosis: a case report from the United kingdom. Int J Clin Exp Pathol, 2009,2:494-497.
